CMC, which will be 51%-owned by Bostik for an investment of around US$ 11 million, will produce specialty cyanoacrylate monomers on an industrial scale at a competitive cost, enabling Bostik to accelerate the development of high value-added engineering adhesives dedicated notably to the electronics, medical equipment and DIY markets.
This investment complements the acquisition of Afinitica in 2018, and enables Bostik to further expand its range of instant engineering adhesives, manufactured through a patented and innovative ‘’crackless’’ process. The adhesives formulated through this process have unique properties, which offer added comfort to the end-users.
This project is perfectly coherent with Bostik's sustainable growth strategy.
It fits well with the trend of replacing traditional bonding with cutting edge, environmentally friendly technologies that enable lightweighting.